Mechanical ventilation: Need for endotracheal intubation and invasive mechanical ventilation
Study summary
We designed this study to dtermine whether invasive mechanical ventilation (MV) would have an impact on the reclassification of patients with acute hypoxemic respiratory failure (AHRF) -treated previously with non-invasive respiratory support- into categories of severity (mild, moderate, and severe). Our hypothesis is that the assessment of PaO2/FiO2 ratio on PEEP greater or equal to 5 cmH2O after intubation, in patients labeled as mild/moderate/severe AHRF while on non-invasive respiratory support, would identify that a marked proportion of patients would change the degree of severity after a brief period of invasive MV
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Patients meeting criteria for AHRF while they are on non-invasive respiratory support.
* We will only include patients who had arterial blood gases (ABG) within a time-frame of the last 5 hours of NIV and the first 5 hours of invasive MV.
* We will only include patients treated with high-flow oxygen nasal cannula (HFNC), or continuous positive airway pressure (CPAP), or bilevel positive pressure (BiPAP).
Exclusion Criteria:
* Patients who never required HFNC, or CPAP, or BiPAP before intubation.
* Patients with no ABG during the last 5 hours of NIV before intubation.
* Patients with no ABG during the first 5 hours after initiation of invasive MV.
* Patients treated with inhaled pulmonary vasodilator only before or only after intubation.
Primary outcome measure(s)
Change in the degree of lung severity — 60 days from severe/moderate to moderate/mild, from moderate/mild to mild after a brief period of invasive MV
Trial sites (2)
Facility
City
Region
Status
Rush University Medical Center
Chicago
Illinois
Jesús Villar
Las Palmas de Gran Canaria
Las Palmas
More Hospital Universitario de Gran Canaria Doctor Negrín trials in Spain
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.